Results 1 to 10 of about 1,032 (114)
Primary Hypertrophic Osteoarthropathy With Myelofibrosis. [PDF]
Primary hypertrophic osteoarthropathy (PHO) is a rare autosomal recessive inherited multi-system disorder characterized by a triad of pachydermia, periostosis, and clubbing. PHO was revealed to be caused by the HPGD gene producing 15-prostaglandin dehydrogenase and the SLCO2A1 gene expressing one kind of prostaglandin transporter.
Yousaf M+4 more
europepmc +2 more sources
Incomplete primary hypertrophic osteoarthropathy. [PDF]
A 63-year-old man presented with chronic multiple joint pain and swelling. The symptoms had started in adolescence, progressed for about 10–15 years, and then became constant. There was no associated morning stiffness. Symptoms suggesting any chest or abdominal disease were absent.
Prasad A+3 more
europepmc +5 more sources
Primary hypertrophic osteoarthropathy: genetics, clinical features and management. [PDF]
Primary hypertrophic osteoarthropathy (PHO) is a genetic disorder mainly characterized by clubbing fingers, pachydermia and periostosis. Mutations in the HPGD or SLCO2A1 gene lead to impaired prostaglandin E2 (PGE2) degradation, thus elevating PGE2 levels.
Lu Q, Xu Y, Zhang Z, Li S, Zhang Z.
europepmc +4 more sources
Pachydermoperiostosis or primary hypertrophic osteoarthropathy: A rare clinicoradiologic case.
AbstractPachydermoperiostosis (PDP) or primary hypertrophic osteoarthropathy is a rare syndrome with diverse radiological and clinical features. Though the diagnosis can be made on the basis of the classic clinical and radiological features, it is often missed due to variable presentations.
Rastogi R+5 more
europepmc +4 more sources
Collagen‐Based Hydrogels for Cartilage Regeneration
This review provided an overview of the progress made in research on collagen hydrogels with chondrocytes or stem cells, comprehensively covered the research progress and clinical applications of collagen‐based hydrogels that integrated inorganic or organic materials. Cartilage regeneration remains difficult due to a lack of blood vessels.
Lihui Sun+9 more
wiley +1 more source
ABSTRACT Degenerative osteoarthritis (OA) is recognized as an early‐onset comorbidity of X‐linked hypophosphatemia (XLH), contributing to pain and stiffness and limiting range of motion and activities of daily living. Here, we extend prior findings describing biochemical and cellular changes of articular cartilage (AC) in the phosphate‐wasting ...
Carolyn M Macica, Steven M Tommasini
wiley +1 more source
Primary Hypertrophic Osteoarthropathy with Gastric Hypertrophy [PDF]
Primary hypertrophic osteoarthropathy (HOA) is a rare congenital disease that is not well recognized. Gastric hypertrophy will be infrequently involved; only 3 case reports describe this scarce manifestation in the English-language literature1,2,3. A 19-year-old Chinese male presented with a 4-year history of thickened skin and joint pain and swelling.
Sun, Xue-Feng+10 more
openaire +4 more sources
Complete form of pachydermoperiostosis with good initial response to etoricoxib: A case report
X‐ray of hand showing cortical thickening and periosteal reaction in distal radius ulna and phalynges of hand of a patient with pachydermoperiostosis. Key Clinical Message Pachydermoperiostosis is a rare genetic disorder that closely resembles acromegaly. Diagnosis is usually based on distinct clinical and radiological features. Oral etoricoxib therapy
Abinash Baniya+6 more
wiley +1 more source
Nosology of genetic skeletal disorders: 2023 revision
Abstract The “Nosology of genetic skeletal disorders” has undergone its 11th revision and now contains 771 entries associated with 552 genes reflecting advances in molecular delineation of new disorders thanks to advances in DNA sequencing technology.
Sheila Unger+20 more
wiley +1 more source
A case report of an extremely rare association of ankylosing spondylitis with pachydermoperiostosis
Key Clinical Message We describe a case of a young man with features of pachydermoperiostosis and spondyloarthropathy. By describing this rarity, we aim to help build a database for future studies and construct a management plan that rheumatologists and clinicians can use.
Faiq I. Gorial+2 more
wiley +1 more source